Yep Lamictal and Pristiq both already missed their optimal FDA approval windows anyways so they'll probably both go the same way Keppra and Glucophage have gone ie: Spend $10's of millions of dollars raised from multiple rounds of dilution developing products that end up never translating into a shred of relevant value ever being generated for the company!